Yuhan (YUHNF) Cyclically Adjusted PB Ratio: (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Yuhan Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Yuhan  (OTCPK:YUHNF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Yuhan Cyclically Adjusted PB Ratio Related Terms


Yuhan Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Yuhan's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yuhan Cyclically Adjusted PB Ratio Chart

Yuhan Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.63 2.36 2.80 4.62 4.14

Yuhan Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 3.93 4.44 4.14 3.43

YUHNF vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuhan Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Yuhan's Cyclically Adjusted PB Ratio falls into.



Yuhan Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Yuhan's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Yuhan's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=20.526/125.2360*125.2360
=20.526

Current CPI (Mar. 2026) = 125.2360.

Yuhan Quarterly Data

Book Value per Share CPI Adj_Book
201606 16.327 100.791 20.287
201609 17.456 101.461 21.546
201612 17.612 101.561 21.717
201703 17.579 102.851 21.405
201706 17.952 102.611 21.910
201709 18.225 103.491 22.054
201712 20.382 102.991 24.784
201803 19.670 104.101 23.664
201806 19.471 104.130 23.417
201809 19.120 105.651 22.664
201812 20.258 104.351 24.313
201903 19.070 104.491 22.856
201906 18.346 104.881 21.907
201909 18.131 105.200 21.584
201912 19.455 105.121 23.178
202003 18.800 105.354 22.348
202006 19.625 105.112 23.382
202009 20.827 106.198 24.561
202012 23.362 105.765 27.663
202103 21.714 107.357 25.330
202106 22.186 107.579 25.827
202109 21.489 108.759 24.745
202112 22.676 109.676 25.893
202203 20.653 111.848 23.125
202206 19.964 114.072 21.918
202209 18.291 114.715 19.968
202212 21.460 115.179 23.334
202303 20.127 116.507 21.635
202306 20.143 117.182 21.527
202309 19.789 118.964 20.832
202312 22.010 118.837 23.195
202403 20.297 120.123 21.161
202406 19.832 120.007 20.696
202409 21.228 120.861 21.996
202412 19.454 121.135 20.113
202503 18.917 122.590 19.325
202506 21.018 122.611 21.468
202509 20.700 123.402 21.008
202512 21.046 123.939 21.266
202603 20.526 125.236 20.526

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Yuhan Business Description

Other Exchanges 000105:Korea000100:Korea
Address 74 Noryangjin-ro, Daebang-dong, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplements, household and animal care, and contract manufacturing of active pharmaceutical ingredients. The company offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.